These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 20459695)
1. High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology. Anagnostou VK; Lowery FJ; Zolota V; Tzelepi V; Gopinath A; Liceaga C; Panagopoulos N; Frangia K; Tanoue L; Boffa D; Gettinger S; Detterbeck F; Homer RJ; Dougenis D; Rimm DL; Syrigos KN BMC Cancer; 2010 May; 10():186. PubMed ID: 20459695 [TBL] [Abstract][Full Text] [Related]
2. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma. Ritter JH; Dresler CM; Wick MR Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697 [TBL] [Abstract][Full Text] [Related]
3. Biological markers and DNA flow cytometric analysis in radically resected patients with non-small cell lung cancer. A study of the Perugia Multidisciplinary Team for Thoracic Tumors. Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Di Carlo L; Semeraro A; Daddi G; Darwish S; Stocchi L; Tofanetti FR; Bellezza G; Sidoni A; Tognellini R; Crinò L; Tonato M Tumori; 2008; 94(3):398-405. PubMed ID: 18705409 [TBL] [Abstract][Full Text] [Related]
4. Expression of caveolin-1 is correlated with disease stage and survival in lung adenocarcinomas. Zhan P; Shen XK; Qian Q; Wang Q; Zhu JP; Zhang Y; Xie HY; Xu CH; Hao KK; Hu W; Xia N; Lu GJ; Yu LK Oncol Rep; 2012 Apr; 27(4):1072-8. PubMed ID: 22200856 [TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of CD73 and A2A adenosine receptor expression in non-small-cell lung cancer. Inoue Y; Yoshimura K; Kurabe N; Kahyo T; Kawase A; Tanahashi M; Ogawa H; Inui N; Funai K; Shinmura K; Niwa H; Suda T; Sugimura H Oncotarget; 2017 Jan; 8(5):8738-8751. PubMed ID: 28060732 [TBL] [Abstract][Full Text] [Related]
6. Peroxiredoxin 4 as an independent prognostic marker for survival in patients with early-stage lung squamous cell carcinoma. Hwang JA; Song JS; Yu DY; Kim HR; Park HJ; Park YS; Kim WS; Choi CM Int J Clin Exp Pathol; 2015; 8(6):6627-35. PubMed ID: 26261544 [TBL] [Abstract][Full Text] [Related]
7. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases. Anton RC; Brown RW; Younes M; Gondo MM; Stephenson MA; Cagle PT Hum Pathol; 1997 Sep; 28(9):1079-82. PubMed ID: 9308733 [TBL] [Abstract][Full Text] [Related]
8. PD-1 and PD-L1 Expression in NSCLC Indicate a Favorable Prognosis in Defined Subgroups. Schmidt LH; Kümmel A; Görlich D; Mohr M; Bröckling S; Mikesch JH; Grünewald I; Marra A; Schultheis AM; Wardelmann E; Müller-Tidow C; Spieker T; Schliemann C; Berdel WE; Wiewrodt R; Hartmann W PLoS One; 2015; 10(8):e0136023. PubMed ID: 26313362 [TBL] [Abstract][Full Text] [Related]
9. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456 [TBL] [Abstract][Full Text] [Related]
10. Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer. Sepesi B; Cuentas EP; Canales JR; Behrens C; Correa AM; Vaporciyan A; Weissferdt A; Kalhor N; Moran C; Swisher S; Wistuba I Semin Thorac Cardiovasc Surg; 2017 Autumn; 29(3):408-415. PubMed ID: 29195578 [TBL] [Abstract][Full Text] [Related]
11. The 3' UTR IGF2R-A2/B2 variant is associated with increased tumor growth and advanced stages in non-small cell lung cancer. Kotsinas A; Evangelou K; Sideridou M; Kotzamanis G; Constantinides C; Zavras AI; Douglass CW; Papavassiliou AG; Gorgoulis VG Cancer Lett; 2008 Feb; 259(2):177-85. PubMed ID: 18037232 [TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 2--a predictor of outcome for patients irradiated for stage II-III non-small-cell lung cancer. Rades D; Setter C; Dahl O; Schild SE; Noack F Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):442-7. PubMed ID: 20950963 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. Dziadziuszko R; Merrick DT; Witta SE; Mendoza AD; Szostakiewicz B; Szymanowska A; Rzyman W; Dziadziuszko K; Jassem J; Bunn PA; Varella-Garcia M; Hirsch FR J Clin Oncol; 2010 May; 28(13):2174-80. PubMed ID: 20351332 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance and prognostic role of EZH2 expression in non-small cell lung cancer. Kim NY; Pyo JS Pathol Res Pract; 2017 Jul; 213(7):778-782. PubMed ID: 28554757 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival. He LR; Ma NF; Chen JW; Li BK; Guan XY; Liu MZ; Xie D Oncotarget; 2015 Oct; 6(31):31181-90. PubMed ID: 26360781 [TBL] [Abstract][Full Text] [Related]
16. Analysis of MAT3 gene expression in NSCLC. Zheng S; Du Y; Chu H; Chen X; Li P; Wang Y; Ma Y; Wang H; Zang W; Zhang G; Zhao G Diagn Pathol; 2013 Oct; 8():166. PubMed ID: 24107548 [TBL] [Abstract][Full Text] [Related]
17. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer. Mo D; He F Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019 [TBL] [Abstract][Full Text] [Related]
18. Modeling the overall survival of patients with advanced-stage non-small cell lung cancer using data of routine laboratory tests. Zhang K; Lai Y; Axelrod R; Campling B; Hyslop T; Civan J; Solomides C; Myers RE; Lu B; Bar Ad V; Li B; Ye Z; Yang H Int J Cancer; 2015 Jan; 136(2):382-91. PubMed ID: 24866905 [TBL] [Abstract][Full Text] [Related]
19. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system. Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848 [TBL] [Abstract][Full Text] [Related]
20. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Volm M; Koomägi R Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]